Episode
E136: Secukinumab in PMR (REPLENISH)
- Published
- Jun 15, 2026
- Duration seconds
- 819
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e136-secukinumab-in-pmr-replenish/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e136-secukinumab-in-pmr-replenish.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I would bet on FDA approval in the near future. Some interesting tidbits and of course a weird safety thing we now have to grapple with. Be sure to go to boardsbank.com! Free rheumatology board review, >1000 questions! Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2602567